Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of linaclotide in adults with IBS-C in China
ChiCTR2100052551Phase 4Completed
- Sponsor
- Second Hospital of Shandong University
- Start
- Sep 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of linaclotide in irritable bowel syndrome (IBS), sponsored by Second Hospital of Shandong University. Primary endpoints: Defecation, Abdominal symptoms and 4 more. Started Sep 2020; status: completed.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on ChiCTR2100052551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052551.